UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Perfusion Estimated With Rapid Dynamic Contrast-Enhanced Magnetic Resonance Imaging Correlates Inversely With Vascular Endothelial Growth Factor Expression and Pimonidazole Staining in Head-and-Neck Cancer: A Pilot Study

International journal of radiation oncology, biology, physics, 2011-11, Vol.81 (4), p.1176-1183

2011

Volltextzugriff (PDF)

Prognostic value of hypoxia-associated markers in advanced larynx and hypopharynx squamous cell carcinoma

The Laryngoscope, 2015-01, Vol.125 (1), p.E8-E15

2015

Volltextzugriff (PDF)

Osteoradionecrosis in Head-and-Neck Cancer Has a Distinct Genotype-Dependent Cause

International journal of radiation oncology, biology, physics, 2012-03, Vol.82 (4), p.1479-1484

2012

Volltextzugriff (PDF)

Randomized Phase 3 Trial of the Hypoxia Modifier Nimorazole Added to Radiation Therapy With Benefit Assessed in Hypoxic Head and Neck Cancers Determined Using a Gene Signature (NIMRAD)

International journal of radiation oncology, biology, physics, 2024-07, Vol.119 (3), p.771-782

2024

Volltextzugriff (PDF)

Evaluation of Larynx-Sparing Techniques With IMRT When Treating the Head and Neck

International journal of radiation oncology, biology, physics, 2008-10, Vol.72 (2), p.617-622

2008

Volltextzugriff (PDF)

Prospective evaluation of relationships between radiotherapy dose to masticatory apparatus and trismus

Acta oncologica, 2018-08, Vol.57 (8), p.1038-1042

2018

Volltextzugriff (PDF)

Comparison of patient-reported late treatment toxicity (LENT–SOMA) with quality of life (EORTC QLQ-C30 and QLQ-H&N35) assessment after head and neck radiotherapy

Radiotherapy and oncology, 2010-11, Vol.97 (2), p.270-275

2010

Volltextzugriff (PDF)

Prognostic Significance of Tumor Hypoxia Inducible Factor–1α Expression for Outcome After Radiotherapy in Oropharyngeal Cancer

International journal of radiation oncology, biology, physics, 2008-12, Vol.72 (5), p.1551-1559

2008

Volltextzugriff (PDF)

IMRT dose fractionation for head and neck cancer: Variation in current approaches will make standardisation difficult

Acta oncologica, 2009, Vol.48 (3), p.431-439

2009

Volltextzugriff (PDF)

Indications for Salivary Gland Radiotherapy

Advances in oto-rhino-laryngology, 2016, Vol.78, p.141

2016

Volltextzugriff (PDF)

Mucosal melanoma of the head and neck: radiotherapy or surgery?

Journal of otolaryngology-head and neck surgery, 2010-08, Vol.39 (4), p.385-392

2010

Volltextzugriff (PDF)

Metastatic renal cell carcinoma to the nose and paranasal sinuses

Head & neck, 2000-10, Vol.22 (7), p.722-727

2000

Volltextzugriff (PDF)

Results of a phase I study to determine the maximum tolerated dose of capecitabine when given concurrently with radical radiotherapy in the treatment of squamous cell carcinoma of the head and neck

Radiotherapy and oncology, 2004-04, Vol.71 (1), p.81-84

2004

Volltextzugriff (PDF)

Randomized Phase 3 Trial of the Hypoxia Modifier Nimorazole Added to Radiation Therapy With Benefit Assessed in Hypoxic Head and Neck Cancers Determined Using a Gene Signature (NIMRAD)

International journal of radiation oncology, biology, physics, 2023-12

2023

Volltextzugriff (PDF)

Prognostic Significance of Tumor Hypoxia Inducible Factor-1a Expression for Outcome After Radiotherapy in Oropharyngeal Cancer

International journal of radiation oncology, biology, physics, 2008-12, Vol.72 (5), p.1551-1559

2008

Volltextzugriff (PDF)

The Impact of Anatomic Change on Pencil Beam Scanning in the Treatment of Oropharynx Cancer

International journal of particle therapy, 2015-09, Vol.2 (2), p.394-403

2015

Volltextzugriff (PDF)

Prognostic Significance of Tumor Hypoxia Inducible Factor-1{alpha} Expression for Outcome After Radiotherapy in Oropharyngeal Cancer

International journal of radiation oncology, biology, physics, 2008-12, Vol.72 (5)

2008

Volltextzugriff (PDF)

Prognostic significance of tumor hypoxia inducible factor-1alpha expression for outcome after radiotherapy in oropharyngeal cancer

International journal of radiation oncology, biology, physics, 2008-12, Vol.72 (5), p.1551-1559

2008

Volltextzugriff (PDF)

Metastatic renal cell carcinoma to the nose and paranasal sinuses

Head & Neck, 2000, Vol.22 (7), p.722-727

2000

Volltextzugriff (PDF)

Image-based Data Mining to Probe Dosimetric Correlates of Radiation-induced Trismus

International journal of radiation oncology, biology, physics, 2018-11, Vol.102 (4), p.1330-1338

2018

Volltextzugriff (PDF)

Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers

Cancer research (Chicago, Ill.), 2007-04, Vol.67 (7), p.3441-3449

2007

Volltextzugriff (PDF)

NeuroX, a fast and efficient genotyping platform for investigation of neurodegenerative diseases

Neurobiology of aging, 2015-03, Vol.36 (3), p.1605.e7-1605.e12

2015

Volltextzugriff (PDF)

Use of a novel atlas for muscles of mastication to reduce inter observer variability in head and neck radiotherapy contouring

Radiotherapy and oncology, 2019-01, Vol.130, p.56-61

2019

Volltextzugriff (PDF)

Tumor Epression of Major Vault Protein is an Adverse Prognostic Factor for Radiotherapy Outcome in Oropharyngeal Carcinoma

International journal of radiation oncology, biology, physics, 2007-09, Vol.69 (1), p.133-140

2007

Volltextzugriff (PDF)

Pre-trial quality assurance processes for an intensity-modulated radiation therapy (IMRT) trial: PARSPORT, a UK multicentre Phase III trial comparing conventional radiotherapy and parotid-sparing IMRT for locally advanced head and neck cancer

British journal of radiology, 2009-07, Vol.82 (979), p.585-594

2009

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(26)

Publikationsform

Sprache

Englisch
(28)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Humans
(17)
Life Sciences & Biomedicine
(17)
Science & Technology
(17)
Oncology
(12)
Female
(11)
Radiotherapy
(11)
Aged
(10)
Male
(10)
Middle Aged
(10)
Otorhinolaryngology
(9)
Radiology, Nuclear Medicine & Medical Imaging
(9)
Adult
(8)
Head And Neck Neoplasms - Radiotherapy
(8)
Radiotherapy Dosage
(8)
Aged, 80 And Over
(7)
Head
(6)
Hematology, Oncology And Palliative Medicine
(6)
Neck
(6)
Radiology And Nuclear Medicine
(6)
Biological And Medical Sciences
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Perfusion Estimated With Rapid Dynamic Contrast-Enhanced Magnetic Resonance Imaging Correlates Inversely With Vascular Endothelial Growth Factor Expression and Pimonidazole Staining in Head-and-Neck Cancer: A Pilot Study

Prognostic value of hypoxia-associated markers in advanced larynx and hypopharynx squamous cell carcinoma

Osteoradionecrosis in Head-and-Neck Cancer Has a Distinct Genotype-Dependent Cause

Randomized Phase 3 Trial of the Hypoxia Modifier Nimorazole Added to Radiation Therapy With Benefit Assessed in Hypoxic Head and Neck Cancers Determined Using a Gene Signature (NIMRAD)

Evaluation of Larynx-Sparing Techniques With IMRT When Treating the Head and Neck

Prospective evaluation of relationships between radiotherapy dose to masticatory apparatus and trismus

Comparison of patient-reported late treatment toxicity (LENT–SOMA) with quality of life (EORTC QLQ-C30 and QLQ-H&N35) assessment after head and neck radiotherapy

Prognostic Significance of Tumor Hypoxia Inducible Factor–1α Expression for Outcome After Radiotherapy in Oropharyngeal Cancer

IMRT dose fractionation for head and neck cancer: Variation in current approaches will make standardisation difficult

Indications for Salivary Gland Radiotherapy

Mucosal melanoma of the head and neck: radiotherapy or surgery?

Metastatic renal cell carcinoma to the nose and paranasal sinuses

Results of a phase I study to determine the maximum tolerated dose of capecitabine when given concurrently with radical radiotherapy in the treatment of squamous cell carcinoma of the head and neck

Randomized Phase 3 Trial of the Hypoxia Modifier Nimorazole Added to Radiation Therapy With Benefit Assessed in Hypoxic Head and Neck Cancers Determined Using a Gene Signature (NIMRAD)

Prognostic Significance of Tumor Hypoxia Inducible Factor-1a Expression for Outcome After Radiotherapy in Oropharyngeal Cancer

The Impact of Anatomic Change on Pencil Beam Scanning in the Treatment of Oropharynx Cancer

Prognostic Significance of Tumor Hypoxia Inducible Factor-1{alpha} Expression for Outcome After Radiotherapy in Oropharyngeal Cancer

Prognostic significance of tumor hypoxia inducible factor-1alpha expression for outcome after radiotherapy in oropharyngeal cancer

Metastatic renal cell carcinoma to the nose and paranasal sinuses

Image-based Data Mining to Probe Dosimetric Correlates of Radiation-induced Trismus

Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers

NeuroX, a fast and efficient genotyping platform for investigation of neurodegenerative diseases

Use of a novel atlas for muscles of mastication to reduce inter observer variability in head and neck radiotherapy contouring

Tumor Epression of Major Vault Protein is an Adverse Prognostic Factor for Radiotherapy Outcome in Oropharyngeal Carcinoma

Pre-trial quality assurance processes for an intensity-modulated radiation therapy (IMRT) trial: PARSPORT, a UK multicentre Phase III trial comparing conventional radiotherapy and parotid-sparing IMRT for locally advanced head and neck cancer

Suchergebnisse filtern